Mirae Asset Global Etfs Holdings Ltd. Foghorn Therapeutics Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $56.2 Billion
- Q3 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 15,378 shares of FHTX stock, worth $72,122. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,378
Previous 17,908
14.13%
Holding current value
$72,122
Previous $84,000
10.71%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding FHTX
# of Institutions
88Shares Held
37MCall Options Held
100Put Options Held
0-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$59.4 Million22.92% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$24.9 Million1.4% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.26MShares$15.3 Million0.3% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL2.46MShares$11.5 Million0.0% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$10.8 Million0.01% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $195M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...